The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids - Tập 1483 - Trang 285-293 - 2000
Mark Abramovitz1, Mohammed Adam1, Yves Boie1, Marie-Claude Carrière1, Danielle Denis1, Claude Godbout1, Sonia Lamontagne1, Chantal Rochette1, Nicole Sawyer1, Nathalie M Tremblay1, Michel Belley1,2, Michel Gallant1,2, Claude Dufresne1,2, Yves Gareau1,2, Rejean Ruel1,2, Helene Juteau1,2, Marc Labelle1,2, Nathalie Ouimet1,2, Kathleen M Metters1
1Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Box 1005 Pointe-Claire-Dorval, Que. H9R 4P8, Canada
2Department of Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, Pointe-Claire-Dorval, Que. H9R 4P8, Canada

Tài liệu tham khảo

Funk, 1993, Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype, J. Biol. Chem., 268, 26767, 10.1016/S0021-9258(19)74379-8

Regan, 1994, Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype, Mol. Pharmacol., 46, 213

Adam, 1994, Cloning and expression of three isoforms of the human EP3 prostanoid receptor, FEBS Lett., 338, 170, 10.1016/0014-5793(94)80358-7

Bastien, 1994, Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype, J. Biol. Chem., 269, 11873, 10.1016/S0021-9258(17)32654-6

Abramovitz, 1994, Cloning and expression of a cDNA for the human prostanoid FP receptor, J. Biol. Chem., 269, 2632, 10.1016/S0021-9258(17)41991-0

Boie, 1995, Molecular cloning and characterization of the human prostanoid DP receptor, J. Biol. Chem., 270, 18910, 10.1074/jbc.270.32.18910

Boie, 1994, Cloning and expression of a cDNA for the human prostanoid IP receptor, J. Biol. Chem., 269, 12173, 10.1016/S0021-9258(17)32697-2

Hirata, 1991, Cloning and expression of cDNA for a human thromboxane A2 receptor, Nature, 349, 617, 10.1038/349617a0

Schmid, 1995, Splice variants of the Human EP3 Receptor for Prostaglandin E2, Eur. J. Pharmacol., 228, 23

Raychowdhury, 1994, Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor, J. Biol. Chem., 269, 19256, 10.1016/S0021-9258(17)32161-0

Kiriyama, 1997, Ligand binding specificies of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells, Br. J. Pharmacol., 122, 217, 10.1038/sj.bjp.0701367

Feldman, 1972, Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting, Anal. Biochem., 48, 317, 10.1016/0003-2697(72)90084-X

Wright, 1998, Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist, Br. J. Pharmacol., 123, 1317, 10.1038/sj.bjp.0701708

Sugimoto, 1993, Two isoforms of the EP3 receptor with different carboxyl-terminal domains, J. Biol. Chem., 268, 2712, 10.1016/S0021-9258(18)53832-1

Negishi, 1993, Functional interaction of prostaglandin E receptor EP3 subtype with guanine nucleotide-binding proteins, showing low-affinity ligand binding, Biochim. Biophys. Acta, 1175, 343, 10.1016/0167-4889(93)90227-G

Irie, 1994, The C-terminus of the prostaglandin-E-receptor EP3 subtype is essential for activation of GTP-binding protein, Eur. J. Biochem., 224, 161, 10.1111/j.1432-1033.1994.tb20007.x

R.A. Coleman, L. Kennedy, P.P.A. Humphrey, K. Bunce, P. Lumley, Prostanoids and their receptors, in: C. Hansch, P.G. Sammea, J.B. Taylor, J.C. Emmett (Eds.), Comprehensive Medicinal Chemistry, Vol. 3, Pergamon Press, Oxford, pp. 643–714.

Coleman, 1994, International Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes, Pharmacol. Rev., 46, 205

Hallinan, 1994, 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H0-carboxylic acid, 2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): a potent PGE2 antagonist and analgesic, Bioorg. Med. Chem. Lett., 3, 509, 10.1016/0960-894X(94)80027-8

E.A. Hallinan, T.J. Hagan, R.K. Husa, S. Tsymbalov, S.N. Rao, J.-P. vanHoeck, M.F. Rafferty, A. Stapelfeld, M.A. Savage, M. Reichman, N-Substituted dibenzoxazepines as analgesic PGE2 antagonists, J. Med. Chem. 36 (1993) 3293–3299.

Woodward, 1995, 6-Isopropoxy-9-oxoanthene-2-carboxylic acid (AH6809), a human EP2 receptor antagonist, Biochem. Pharmacol., 50, 1731, 10.1016/0006-2952(95)02035-7

Higginbotham, 1996, Will latanoprost be the ‘wonder’ drug of the ’90’s for the treatment of glaucoma?, Arch. Ophthalmol., 114, 998, 10.1001/archopht.1996.01100140206015

Bito, 1993, The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management, J. Lipid Med., 6, 535

Thông tin
Thông tin xuất bản

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Tập 1483

285-293

Thông tin tác giả